Topic Statement: Divi's Laboratories has shown resilience amidst the broad market correction, with stable price movements and potential for accumulation near the 180-day moving average.
Key points: 1. Company reported a profit growth of 64% QoQ for the third quarter. 2. Price broke down from the up-trending channel, transitioning into a sideways pattern. 3. Strong resistance is present at the 6000 level. 4. The stock repeatedly approaches the 180-day moving average, presenting a good buying opportunity.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.